Eli Lilly plans a $3 billion expansion of its Wisconsin facility, creating 750 skilled jobs and boosting production capacity for critical medicines with advanced automation.
Eli Lilly Investments In Production Reach $23 Billion With Additional $3 Billion Expansion At US Facility